Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
1011000
SharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock options (tax-qualified stock options)
Who receives how much
1,011,000 shares of common stock (10,110 stock acquisition rights, 100 shares per right; if all rights are exercised)
Employees of the Company, including executive officers, and directors and employees of the Company's subsidiaries, including executive officersEquivalent to 1,011,000 shares (10,110 rights)
The lower thin line represents the existing number of shares to which these shares will be added.
The share acquisition rights will be issued free of charge
Amount of funds to be raised
No payment is required for the stock acquisition rights. Estimated net proceeds: Not disclosed
Existing Shares and Increase
+0.70%Rate of increase
137,996,343 shares139,007,343Shares
Approximately 0.7% (based on 137,996,343 issued shares, excluding treasury shares, as of the end of February 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Equal to the closing price on 23 March 2026. Adjustment provisions apply in connection with stock splits, reverse stock splits, the issuance of new shares, the disposal of treasury shares and other events. The lower limit of the adjustment is Not disclosed
Exercise period
From 2 July 2029 to 29 September 2034
Number of Stock Acquisition Rights
Total number issued: 10,110. Number of unexercised rights: Not disclosed
Reason for acquisition without consideration
If approval is obtained at a shareholders meeting for a merger or other transaction, or if holders become unable to exercise the rights under the exercise conditions, the Company may acquire all or the relevant stock acquisition rights free of charge on a date separately determined by the Board of Directors.
Categories and Number of Persons Covered
10,110 rights will be allocated to employees of the Company, including executive officers, and directors and employees of the Company's subsidiaries, including executive officers. The number of eligible recipients will be disclosed once determined.
Payment date
No payment of money is required in exchange for the stock acquisition rights.
Basis for determining the amount to be paid
The exercise price will be equal to the closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on 23 March 2026, or, if no trading takes place, the closing price on the most recent trading day.
Procedures under the Corporate Code of Conduct
The issuance was resolved at a meeting of the Board of Directors held on 23 March 2026. Whether an independent third-party opinion will be obtained and whether shareholder approval will be sought: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock options (tax-qualified stock options) |
| Number of shares to be issued or disposed of | 1,011,000 shares of common stock (10,110 stock acquisition rights, 100 shares per right; if all rights are exercised) |
| Issue price and disposal price | The share acquisition rights will be issued free of charge |
| Amount of funds to be raised | No payment is required for the stock acquisition rights. Estimated net proceeds: Not disclosed |
| Payment date | No payment of money is required in exchange for the stock acquisition rights. |
| Intended allottee | Name Employees of the Company, including executive officers, and directors and employees of the Company's subsidiaries, including executive officers / Number of Shares Equivalent to 1,011,000 shares (10,110 rights) |
| Dilution Rate | Approximately 0.7% (based on 137,996,343 issued shares, excluding treasury shares, as of the end of February 2026) |
| Total number of issued shares | 137,996,343 shares (as of the end of February 2026, excluding treasury shares) → Up to 139,007,343 shares (if all stock acquisition rights are exercised)（Approximately 0.7%） |
| Basis for determining the amount to be paid | The exercise price will be equal to the closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on 23 March 2026, or, if no trading takes place, the closing price on the most recent trading day. |
| Exercise price | Equal to the closing price on 23 March 2026. Adjustment provisions apply in connection with stock splits, reverse stock splits, the issuance of new shares, the disposal of treasury shares and other events. The lower limit of the adjustment is Not disclosed |
| Exercise period | From 2 July 2029 to 29 September 2034 |
| Number of Stock Acquisition Rights | Total number issued: 10,110. Number of unexercised rights: Not disclosed |
| Reason for acquisition without consideration | If approval is obtained at a shareholders meeting for a merger or other transaction, or if holders become unable to exercise the rights under the exercise conditions, the Company may acquire all or the relevant stock acquisition rights free of charge on a date separately determined by the Board of Directors. |
| Categories and Number of Persons Covered | 10,110 rights will be allocated to employees of the Company, including executive officers, and directors and employees of the Company's subsidiaries, including executive officers. The number of eligible recipients will be disclosed once determined. |
| Procedures under the Corporate Code of Conduct | The issuance was resolved at a meeting of the Board of Directors held on 23 March 2026. Whether an independent third-party opinion will be obtained and whether shareholder approval will be sought: Not disclosed |
Items this document does not state (13)
Total issue valueEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen group cohesion and enhance motivation and morale toward expanding business performance and increasing corporate value over the medium to long term.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.